葡萄糖-6-磷酸脱氢酶缺乏的腰椎间盘突出症患者行医用三氧髓核消融术的安全性  

Safety of the patients with G6PD deficiency in the treatment of lumbar intervertebral disc herniation with medical ozone ablation of nucleus pulposus

作　　者：黄格朗[1] 周凯[1] 周德文[1] 郭礼[1] 卢燕[1] 

机构地区：[1]广西贵港市人民医院康复科,537100

出　　处：《实用疼痛学杂志》2013年第2期120-123,共4页Pain Clinic Journal

基　　金：广西壮族自治区卫生厅自筹经费课题（2012366）

摘　　要：目的观察葡萄糖-6-磷酸脱氢酶（G6PD）缺乏患者行医用三氧髓核消融术治疗腰椎间盘突出症的安全性。方法确诊为G6PD缺乏的腰椎间盘突出症患者11例行医用三氧髓核消融术，于术前、术后1周、术后半年进行血常规、肝肾功能、凝血功能等检查，观察患者是否出现肝肾功能损害及溶血等现象。结果G6PD缺乏患者的术前及术后各指标比较差异均无统计学意义（P〉0．05）。结论G6PD缺乏的腰椎间盘突出症患者行医用三氧髓核消融术相对安全。Objective To observe the safety of patients with G6PD deficiency in the treatment of lumbar intervertebral disc herniation with medical ozone ablation of nucleus pulposus. Methods Eleven G6PD deficiency patients with lumbar intervertebral disc herniation received medical ozone ablation of nucleus pulposus. At the pretreatment, 1 week and half year after the treatment, liver and kidney function, blood clotting function and other tests were checked, then whether there was a damage in the liver and kidney function or hemolysis were examined. Results No significant difference was found in the liver and kidney function, blood clotting function and other tests at different times after the treatment （P〈0.05）. Conclusion It is relatively safe for patients with G6PD deficiency to receive medical ozone ablation of nucleus pulposus in the treatment of intervertebral disc herniation.

关 键 词：葡萄糖-6-磷酸脱氢酶 三氧 导管消融术 腰椎间盘突出症 

分 类 号：R681.53[医药卫生—骨科学]